Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Valgimigli

Showing results (1-10 of 799) with videos related to

Pageof 80
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
AMI on the moveMarco Valgimigli
JACC. Cardiovascular Interventions|October 25, 2014
Shifting the focus to recurrences: so good we can afford it or too bad we cannot avoid it?Marco Valgimigli
European Heart Journal|January 19, 2018
'Ten Commandments' of the 2017 ESC DAPT focused update GuidelinesMarco Valgimigli
Lancet (London, England)|May 7, 2019
The MATRIX trial - Author's replyMarco Valgimigli
European Heart Journal|January 19, 2018
The ESC DAPT Guidelines 2017Marco Valgimigli
European Heart Journal|December 28, 2018
The remarkable story of a wonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin!Marco Valgimigli
Circulation|November 19, 2014
Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justifiedMarco Valgimigli
American Heart Journal|December 3, 2014
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX programMarco Valgimigli,
Evidence-Based Cardiovascular Medicine|December 29, 2005
Direct comparisons of sirolimus-eluting and paclitaxel-eluting stents are needed. CommentaryMarco Valgimigli
Current Opinion in Cardiology|December 2, 2011
Clinical dilemmas on managing antiplatelet therapies after percutaneous coronary intervention: benefits versus risksMarco Valgimigli
Pageof 80

Showing results (1-10 of 799) with videos related to

Sort By:
Pageof 80
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
AMI on the moveMarco Valgimigli
JACC. Cardiovascular Interventions|October 25, 2014
Shifting the focus to recurrences: so good we can afford it or too bad we cannot avoid it?Marco Valgimigli
European Heart Journal|January 19, 2018
'Ten Commandments' of the 2017 ESC DAPT focused update GuidelinesMarco Valgimigli
Lancet (London, England)|May 7, 2019
The MATRIX trial - Author's replyMarco Valgimigli
European Heart Journal|January 19, 2018
The ESC DAPT Guidelines 2017Marco Valgimigli
European Heart Journal|December 28, 2018
The remarkable story of a wonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin!Marco Valgimigli
Circulation|November 19, 2014
Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justifiedMarco Valgimigli
American Heart Journal|December 3, 2014
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX programMarco Valgimigli,
Evidence-Based Cardiovascular Medicine|December 29, 2005
Direct comparisons of sirolimus-eluting and paclitaxel-eluting stents are needed. CommentaryMarco Valgimigli
Current Opinion in Cardiology|December 2, 2011
Clinical dilemmas on managing antiplatelet therapies after percutaneous coronary intervention: benefits versus risksMarco Valgimigli
Pageof 80